chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Scan with contrast abnormal, Ultrasound Doppler normal, Walking aid user, X-ray limb abnormal
Clinical narrative: discharged. 58-year-old man presenting to our institution with shortness of breath for a day.  He reported that the shortness of breath was worsened with exertion, alleviated at rest.  He had some lightheadedness, which is longstanding since his diagnosis with COVID-19 in 2020. Patient is homeless, and lives currently at Facility.  He has a history of COVID-19 leading to ARDS in 2020, and he did recover without the needs for oxygen.  In the emergency department he was found to be hypoxemic on room air, 85%.  He tested positive for COVID-19.  EKG and chest x-ray as well as CT head did not reveal acute findings.  CT cervical spine revealed no acute findings.  Shoulder x-ray was consistent with arthritis.  He was admitted to the institution for further management of COVID-19 pneumonia with hypoxemia.  In regards to his COVID-19 infection, the patient has been vaccinated with the Johnson and Johnson vaccination by has not received a booster.  Given his hypoxemia he was placed on dexamethasone 6 mg daily.  He also was placed on remdesivir, though this was discontinued because of his bradycardia.  Patient was able to wean off of oxygen at rest, however he was identified to require 2 L of oxygen with activity.  Because of this, he was not a candidate to go back to Facility until he was out of his isolation.  Patient did have an intermittent pleuritic chest pain, with elevated D-dimer, upper and lower extremity Dopplers unrevealing, CT angiogram thorax revealed no pulmonary embolism however did reveal some minimal patchy airspace disease in left lower lobe and coronary calcification was as well as severe emphysema.  EKG revealed no evidence of ischemia.  Patient noted to have resting bradycardia as well as bradycardia overnight.  He had normal chronotropic response.  It is recommended he be tested for sleep study as an outpatient.  Patient experienced no complication from his alcohol use disorder, no withdrawal, received thiamine, folic acid and multivitamin. Treated for body lice, clinically improving. Seen by PT and OT for frequent falls, will need to use a cane. Patient continued to improve through out his stay and was performing his usual activities of daily living on the day of discharge.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Headache, Laboratory test
Clinical narrative: Dose 2 within four hours into her shift running 101. fever 103.5 fever 3-4 days. Brain fog and new diagnosis of asthma since having COVID March 2020. Joint pain and constant fatigue and was very active and 12 hours of sleep from 6 hours a day. One shift a week sleep 2-3 days on and off. Constant headache. Used to work three 12 hours a shift or 40 hour work week and unable to perform at this level since vaccinations. Seem pumalogy since the vaccination and the diagnosis of Asthma was diagnosed in 2021 after the offices re-opened. Urgent care in 2021. X-ray and referred to pulmonology, was put on asthma medication and was advised with note that she had difficulty with wearing a mask. Advair, Singular and Trilogy. X-ray and referred to pulmonology, was put on asthma medication and was advised with note that she had difficulty with wearing a mask. X-ray, EXG, dye contrast, blood clots test, and put her on Trilogy Summer 2021.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, X-ray
Clinical narrative: Dose 2 within four hours into her shift running 101. fever 103.5 fever 3-4 days. Brain fog and new diagnosis of asthma since having COVID March 2020. Joint pain and constant fatigue and was very active and 12 hours of sleep from 6 hours a day. One shift a week sleep 2-3 days on and off. Constant headache. Used to work three 12 hours a shift or 40 hour work week and unable to perform at this level since vaccinations. Seem pumalogy since the vaccination and the diagnosis of Asthma was diagnosed in 2021 after the offices re-opened. Urgent care in 2021. X-ray and referred to pulmonology, was put on asthma medication and was advised with note that she had difficulty with wearing a mask. Advair, Singular and Trilogy. X-ray and referred to pulmonology, was put on asthma medication and was advised with note that she had difficulty with wearing a mask. X-ray, EXG, dye contrast, blood clots test, and put her on Trilogy Summer 2021.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Dyspnoea, Grip strength decreased, Headache
Clinical narrative: Severe headache onset immediately after vaccine and continued at this severity for 3 days, patient is still experiencing a headache today but not as severe. Her eyes were severely red post-vaccine. She experienced fever/chills the day following the vaccine and persisted for 5 days. She developed a severe cough to the extent that her ribs were in pain and having to keel over. The cough persists today but not as intolerable. She describes not being able to take a full, deep breath. She took aspirin and Tylenol for the headache which did not provide any relief. She took DayQuil for the cough. Patient states she developed a tremor in both hands post-vaccine where she has trouble gripping, but no loss of sensation. Patient states she has no appetite.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Musculoskeletal chest pain, Ocular hyperaemia, Pyrexia, Tremor
Clinical narrative: Severe headache onset immediately after vaccine and continued at this severity for 3 days, patient is still experiencing a headache today but not as severe. Her eyes were severely red post-vaccine. She experienced fever/chills the day following the vaccine and persisted for 5 days. She developed a severe cough to the extent that her ribs were in pain and having to keel over. The cough persists today but not as intolerable. She describes not being able to take a full, deep breath. She took aspirin and Tylenol for the headache which did not provide any relief. She took DayQuil for the cough. Patient states she developed a tremor in both hands post-vaccine where she has trouble gripping, but no loss of sensation. Patient states she has no appetite.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Sex: F
Vaccine: UNK
Symptoms: COVID-19, Death
Clinical narrative: covid infection and death
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Ataxia, COVID-19, Confusional state, Facial spasm
Clinical narrative: Tunnel vision, restlessness, unable to control extremities, vomiting, confusion, persistent lethargy, loss of strength over last 8 months, facial spasms. And I still was infected with covid 19
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Restlessness, Tunnel vision, Vomiting
Clinical narrative: Tunnel vision, restlessness, unable to control extremities, vomiting, confusion, persistent lethargy, loss of strength over last 8 months, facial spasms. And I still was infected with covid 19
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Headache, Hypoaesthesia, Impaired work ability, Loss of personal independence in daily activities
Clinical narrative: I had daily headaches for about 3 months.  They were bad enough to impair my daily routine.  My arms and hands would go numb daily.  I'm an IT person so typing was almost impossible.  My legs would  go numb as well but not as bad as my arms.  I could still walk but with trouble.  This happened after both shots.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine positive rechallenge
Clinical narrative: I had daily headaches for about 3 months.  They were bad enough to impair my daily routine.  My arms and hands would go numb daily.  I'm an IT person so typing was almost impossible.  My legs would  go numb as well but not as bad as my arms.  I could still walk but with trouble.  This happened after both shots.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Hospitalization for Covid infection
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Atelectasis, COVID-19, Chest X-ray normal, Cough
Clinical narrative: Patient is a 47 y.o. female with a history of cervical cancer status post chemo/radiation therapy, depression/anxiety, chronic airway obstruction, OSA on BiPAP, hypothyroidism who presented to ED with symptoms of fever, congestion, sore throat, cough, muscle aches and found to be COVID-19 positive.  Patient did previously receive J&J COVID-19 vaccine on 7/15/21 but had not yet received booster. Desaturation noted with ambulation, so admission was requested for further care. CXR normal. LFTs mildly elevated. She received decadron in the ED but was not continued on steroids upon admission given lack of hypoxia. CT angio negative for PE or other acute abnormality. She did receive benadryl and solumedrol as pre-treament for IV contrast allergy. Following the CT, she noted itching of hands, feet, and eyes along with hand swelling and erythema. Planned epi and pepcid, but patient felt better and declined these medications. Allergy profile updated. She remained stable on room air. Labs stable/improving. Planned discharge on 1/21 but patient was feeling symptomatically worse, with stable vitals. She was monitored an additional night and remained stable on room air. She felt comfortable with discharge home on 1/22. She will arrange PCP follow up for hospitalization and was discharged in stable condition.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Erythema, Eye pruritus, Fibrin D dimer increased, Granuloma
Clinical narrative: Patient is a 47 y.o. female with a history of cervical cancer status post chemo/radiation therapy, depression/anxiety, chronic airway obstruction, OSA on BiPAP, hypothyroidism who presented to ED with symptoms of fever, congestion, sore throat, cough, muscle aches and found to be COVID-19 positive.  Patient did previously receive J&J COVID-19 vaccine on 7/15/21 but had not yet received booster. Desaturation noted with ambulation, so admission was requested for further care. CXR normal. LFTs mildly elevated. She received decadron in the ED but was not continued on steroids upon admission given lack of hypoxia. CT angio negative for PE or other acute abnormality. She did receive benadryl and solumedrol as pre-treament for IV contrast allergy. Following the CT, she noted itching of hands, feet, and eyes along with hand swelling and erythema. Planned epi and pepcid, but patient felt better and declined these medications. Allergy profile updated. She remained stable on room air. Labs stable/improving. Planned discharge on 1/21 but patient was feeling symptomatically worse, with stable vitals. She was monitored an additional night and remained stable on room air. She felt comfortable with discharge home on 1/22. She will arrange PCP follow up for hospitalization and was discharged in stable condition.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Liver function test increased, Lymph node calcification, Myalgia, Myelopathy, Oropharyngeal pain
Clinical narrative: Patient is a 47 y.o. female with a history of cervical cancer status post chemo/radiation therapy, depression/anxiety, chronic airway obstruction, OSA on BiPAP, hypothyroidism who presented to ED with symptoms of fever, congestion, sore throat, cough, muscle aches and found to be COVID-19 positive.  Patient did previously receive J&J COVID-19 vaccine on 7/15/21 but had not yet received booster. Desaturation noted with ambulation, so admission was requested for further care. CXR normal. LFTs mildly elevated. She received decadron in the ED but was not continued on steroids upon admission given lack of hypoxia. CT angio negative for PE or other acute abnormality. She did receive benadryl and solumedrol as pre-treament for IV contrast allergy. Following the CT, she noted itching of hands, feet, and eyes along with hand swelling and erythema. Planned epi and pepcid, but patient felt better and declined these medications. Allergy profile updated. She remained stable on room air. Labs stable/improving. Planned discharge on 1/21 but patient was feeling symptomatically worse, with stable vitals. She was monitored an additional night and remained stable on room air. She felt comfortable with discharge home on 1/22. She will arrange PCP follow up for hospitalization and was discharged in stable condition.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Peripheral swelling, Pruritus, Pyrexia, Respiratory tract congestion
Clinical narrative: Patient is a 47 y.o. female with a history of cervical cancer status post chemo/radiation therapy, depression/anxiety, chronic airway obstruction, OSA on BiPAP, hypothyroidism who presented to ED with symptoms of fever, congestion, sore throat, cough, muscle aches and found to be COVID-19 positive.  Patient did previously receive J&J COVID-19 vaccine on 7/15/21 but had not yet received booster. Desaturation noted with ambulation, so admission was requested for further care. CXR normal. LFTs mildly elevated. She received decadron in the ED but was not continued on steroids upon admission given lack of hypoxia. CT angio negative for PE or other acute abnormality. She did receive benadryl and solumedrol as pre-treament for IV contrast allergy. Following the CT, she noted itching of hands, feet, and eyes along with hand swelling and erythema. Planned epi and pepcid, but patient felt better and declined these medications. Allergy profile updated. She remained stable on room air. Labs stable/improving. Planned discharge on 1/21 but patient was feeling symptomatically worse, with stable vitals. She was monitored an additional night and remained stable on room air. She felt comfortable with discharge home on 1/22. She will arrange PCP follow up for hospitalization and was discharged in stable condition.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Scan with contrast normal
Clinical narrative: Patient is a 47 y.o. female with a history of cervical cancer status post chemo/radiation therapy, depression/anxiety, chronic airway obstruction, OSA on BiPAP, hypothyroidism who presented to ED with symptoms of fever, congestion, sore throat, cough, muscle aches and found to be COVID-19 positive.  Patient did previously receive J&J COVID-19 vaccine on 7/15/21 but had not yet received booster. Desaturation noted with ambulation, so admission was requested for further care. CXR normal. LFTs mildly elevated. She received decadron in the ED but was not continued on steroids upon admission given lack of hypoxia. CT angio negative for PE or other acute abnormality. She did receive benadryl and solumedrol as pre-treament for IV contrast allergy. Following the CT, she noted itching of hands, feet, and eyes along with hand swelling and erythema. Planned epi and pepcid, but patient felt better and declined these medications. Allergy profile updated. She remained stable on room air. Labs stable/improving. Planned discharge on 1/21 but patient was feeling symptomatically worse, with stable vitals. She was monitored an additional night and remained stable on room air. She felt comfortable with discharge home on 1/22. She will arrange PCP follow up for hospitalization and was discharged in stable condition.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza virus test negative, Pneumonia, Pneumovirus test positive, SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: Contracted pneumonia for the entirety of November 2021 Required 3 visits to PCP for shots plus antibiotics and steroids
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Fall, Fatigue, Hypoxia
Clinical narrative: Patient is fully vaccinate.  Boosted on 11/23/2021.  Admitting dx: fatigue, fall, hypoxia, pneumonia due to COVID.  Patient placed on decadron, lovenox and Remdesivir.  Oxygen requirements improved and was discharged with home oxygen.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy, Eye irritation, Injection site pain, Injection site pruritus, Pruritus
Clinical narrative: ABOUT 1 WEEK AFTER RECEIVING SECOND MODERNA COVID VACCINE, PATIENT BEGAN EXPERIENCING INTENSE BURNING AND ITCHING AT INJECTION SITE. TREATED WITH BENADRYL AND HYDROCORTISONE CREAM. FINALLY SAW A DETERMOLOGIST ABOUT A MONTH LATER. NOW BEING TREATED WITH PRESCRIPTION STEROID CREAM. 4 MONTHS LATER, CONDITION CONTINUES, BUT HAS SPREAD DOWN TO WRIST, THE UPPER ARM NO LONGER BEING AFFECTED.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy skin, Blood test, COVID-19, Erythema, Peripheral swelling
Clinical narrative: ABOUT 1 WEEK AFTER RECEIVING SECOND MODERNA COVID VACCINE, PATIENT BEGAN EXPERIENCING INTENSE BURNING AND ITCHING AT INJECTION SITE. TREATED WITH BENADRYL AND HYDROCORTISONE CREAM. FINALLY SAW A DETERMOLOGIST ABOUT A MONTH LATER. NOW BEING TREATED WITH PRESCRIPTION STEROID CREAM. 4 MONTHS LATER, CONDITION CONTINUES, BUT HAS SPREAD DOWN TO WRIST, THE UPPER ARM NO LONGER BEING AFFECTED.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, SARS-CoV-2 test positive, Scar, Urticaria
Clinical narrative: ABOUT 1 WEEK AFTER RECEIVING SECOND MODERNA COVID VACCINE, PATIENT BEGAN EXPERIENCING INTENSE BURNING AND ITCHING AT INJECTION SITE. TREATED WITH BENADRYL AND HYDROCORTISONE CREAM. FINALLY SAW A DETERMOLOGIST ABOUT A MONTH LATER. NOW BEING TREATED WITH PRESCRIPTION STEROID CREAM. 4 MONTHS LATER, CONDITION CONTINUES, BUT HAS SPREAD DOWN TO WRIST, THE UPPER ARM NO LONGER BEING AFFECTED.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Sensitive skin, Skin burning sensation
Clinical narrative: ~ Approximately 2-3 weeks after the vaccination, facial skin products (with exfoliants) that I have been using for over a year caused my skin to burn, i.e., a burning sensation and red tender skin on my cheeks and around my eyes. I had to switch to neutral products for sensitive skin. I also tried Claritin and applied Cortizone cream, which didn't seem to help. Within the same time period, I developed a painful and itchy rash on my lower front neck. It went away after a few days.A couple of weeks later (1/1/22), the rash on my neck reappeared and again disappeared after about three days.Everything has returned to normal - there has been no further recurrence of the rash and I'm able to use my regular skin care products again.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Choking, Cough
Clinical narrative: Patient brought to the ED for choking while eating, recent CVA with residual dysphagia.  Found to have a cough and weakness.  Tested positive for COVID-19 1/23/2022  Chest X-ray was clear.  Admitted to the hospital for weakness.  Patient was discharged 1/28/22. Patient previously vaccinated with Moderna 3/12/21 & 04/09/21
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient brought to the ED for choking while eating, recent CVA with residual dysphagia.  Found to have a cough and weakness.  Tested positive for COVID-19 1/23/2022  Chest X-ray was clear.  Admitted to the hospital for weakness.  Patient was discharged 1/28/22. Patient previously vaccinated with Moderna 3/12/21 & 04/09/21
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Client presented for booster vaccination.  Nurse reviewed the list of clients needing a booster and Registration form and vaccinated client with Moderna booster.  After already giving, booster, the nurse again reviewed the paper indicating clients who needed booster.  The booster for this client was due 3/18/21 (year written wrong) and didn't think about the fact it should have been 2022.  She understands she will need to slow down next time and be sure of dates before vaccinating.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Eye pain, Headache, Herpes zoster, Neck pain
Clinical narrative: Started having severe pain in eye, headache, pain in forehead, top and side of head, neck, shoulder, back,  Went to eye doctor, 1/11/22 and diagnosed with shingles.  Prescribed Valacyclovir 1 gm tablets.  On 1/13 saw CNP and she prescribed Prednisone 20 mg for rash.  Symptoms improved some and then worsened again by 1/27 with really severe pain.  Called CNP and she prescribed Tramadol 50 mg.  As of today, still having all symptoms as described above.  (His daughter got same vaccine same day   and was diagnosed with shingles on same day as he was, that is why we are reporting adverse reaction).
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Rash, Sacral pain
Clinical narrative: Started having severe pain in eye, headache, pain in forehead, top and side of head, neck, shoulder, back,  Went to eye doctor, 1/11/22 and diagnosed with shingles.  Prescribed Valacyclovir 1 gm tablets.  On 1/13 saw CNP and she prescribed Prednisone 20 mg for rash.  Symptoms improved some and then worsened again by 1/27 with really severe pain.  Called CNP and she prescribed Tramadol 50 mg.  As of today, still having all symptoms as described above.  (His daughter got same vaccine same day   and was diagnosed with shingles on same day as he was, that is why we are reporting adverse reaction).
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Patient presented to the hospital 1/24/2022 with progressive increasing dyspnea, COVID pneumonia and possible sepsis.  Patient tested positive on 1/24/22.  Onset of symptoms was 1/23/22.  Patient was started on remdesivir and dexamethasone.  Discharged 1/29/22.  Previously vaccinated Pfizer 3/1/21, 3/23/21, 11/19/21
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide normal, Chest pain, Troponin I normal
Clinical narrative: Chest pain the day after COVID-19 vaccine.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Underage before the approval for Pfizer vaccine . Suspected falsification of DOB ? unable to contact guardian
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nasopharyngitis, SARS-CoV-2 test positive
Clinical narrative: Had symptoms of common cold that began on December 27, 2021... Went to local clinic and when checked for Covid-19 tested positive. Quarantined for 10 days. After about 5 days of quarantine no longer had any symptoms. Had minor symptoms but nothing severe during quarantine. Rotated between taking Tylenol and Ibuprofen.Covid 19
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Chronic and persistent diarrhea.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling of body temperature change, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Raised red skin at injection site measuring 2.75" x 1.57" and increasing slowly. Painful, warm to touch. No itching. Have drawn circle around to validate start of size. Skin sensitivity on arms, legs, back, buttocks (similar to mild sunburn sensation), still ongoing. Scalp sensitivity/tenderness for 24 hours (has stopped). Sinus headache/pain when coughing only or bending over. Swollen lymph nodes in left armpit area, still ongoing. Feelings of hot/cold but no fever ongoing. Dizziness started approx. 25 min. while moving head too quickly or standing too quickly and continued approx. until 36 hours. Treating with Tylenol, ice, vitamins.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Lymphadenopathy, Pain of skin, Sensitive skin, Sinus headache
Clinical narrative: Raised red skin at injection site measuring 2.75" x 1.57" and increasing slowly. Painful, warm to touch. No itching. Have drawn circle around to validate start of size. Skin sensitivity on arms, legs, back, buttocks (similar to mild sunburn sensation), still ongoing. Scalp sensitivity/tenderness for 24 hours (has stopped). Sinus headache/pain when coughing only or bending over. Swollen lymph nodes in left armpit area, still ongoing. Feelings of hot/cold but no fever ongoing. Dizziness started approx. 25 min. while moving head too quickly or standing too quickly and continued approx. until 36 hours. Treating with Tylenol, ice, vitamins.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus pain
Clinical narrative: Raised red skin at injection site measuring 2.75" x 1.57" and increasing slowly. Painful, warm to touch. No itching. Have drawn circle around to validate start of size. Skin sensitivity on arms, legs, back, buttocks (similar to mild sunburn sensation), still ongoing. Scalp sensitivity/tenderness for 24 hours (has stopped). Sinus headache/pain when coughing only or bending over. Swollen lymph nodes in left armpit area, still ongoing. Feelings of hot/cold but no fever ongoing. Dizziness started approx. 25 min. while moving head too quickly or standing too quickly and continued approx. until 36 hours. Treating with Tylenol, ice, vitamins.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, Angiogram pulmonary abnormal, COVID-19, COVID-19 pneumonia, Chills
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 3/5/21 (023M20A) Moderna Dose 2 4/7/21 (019B21A) COVID Positive 9/29/21  10/8/21: The patient had fever and chills with shortness of breath and cough with exertion and nausea without vomiting or diarrhea or abdominal pain for about 2 weeks became progressively worsen last 3 days specially shortness of breath while he was walking within the room distance.  No chest pain or palpitation or orthopnea or lower limb swelling or pain.  No known history of venous thromboembolism.   At emergency, his oxygen saturation normal room air but dropped to 84% while he was walking with a in the hallway, his labs show stable CKD and anemia.  CT chest angiogram negative for PE and show bilateral consolidation.  COVID-19 test is positive  10/9/21: Patient is a 88-year-old male admitted to the hospital for dyspnea associated with COVID-19 pneumonia, during the course of his hospital stay patient did not have any fevers or chills, did not require any supplemental oxygen, patient was treated with remdesivir and Decadron. On the day of discharge patient is hemodynamically stable comfortable on room air without any respiratory distress, patient was evaluated by respiratory therapy did not qualify for any home oxygen.  Patient will be discharged to home with oral antibiotic for completion.  Per patient's request VNA and COVID safe at home has been ordered for patient.  Patient recommended follow-up with his PCP within 1 week.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Inappropriate schedule of product administration, Laboratory test abnormal, Lung consolidation
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 3/5/21 (023M20A) Moderna Dose 2 4/7/21 (019B21A) COVID Positive 9/29/21  10/8/21: The patient had fever and chills with shortness of breath and cough with exertion and nausea without vomiting or diarrhea or abdominal pain for about 2 weeks became progressively worsen last 3 days specially shortness of breath while he was walking within the room distance.  No chest pain or palpitation or orthopnea or lower limb swelling or pain.  No known history of venous thromboembolism.   At emergency, his oxygen saturation normal room air but dropped to 84% while he was walking with a in the hallway, his labs show stable CKD and anemia.  CT chest angiogram negative for PE and show bilateral consolidation.  COVID-19 test is positive  10/9/21: Patient is a 88-year-old male admitted to the hospital for dyspnea associated with COVID-19 pneumonia, during the course of his hospital stay patient did not have any fevers or chills, did not require any supplemental oxygen, patient was treated with remdesivir and Decadron. On the day of discharge patient is hemodynamically stable comfortable on room air without any respiratory distress, patient was evaluated by respiratory therapy did not qualify for any home oxygen.  Patient will be discharged to home with oral antibiotic for completion.  Per patient's request VNA and COVID safe at home has been ordered for patient.  Patient recommended follow-up with his PCP within 1 week.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Oxygen saturation decreased, Pyrexia, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 3/5/21 (023M20A) Moderna Dose 2 4/7/21 (019B21A) COVID Positive 9/29/21  10/8/21: The patient had fever and chills with shortness of breath and cough with exertion and nausea without vomiting or diarrhea or abdominal pain for about 2 weeks became progressively worsen last 3 days specially shortness of breath while he was walking within the room distance.  No chest pain or palpitation or orthopnea or lower limb swelling or pain.  No known history of venous thromboembolism.   At emergency, his oxygen saturation normal room air but dropped to 84% while he was walking with a in the hallway, his labs show stable CKD and anemia.  CT chest angiogram negative for PE and show bilateral consolidation.  COVID-19 test is positive  10/9/21: Patient is a 88-year-old male admitted to the hospital for dyspnea associated with COVID-19 pneumonia, during the course of his hospital stay patient did not have any fevers or chills, did not require any supplemental oxygen, patient was treated with remdesivir and Decadron. On the day of discharge patient is hemodynamically stable comfortable on room air without any respiratory distress, patient was evaluated by respiratory therapy did not qualify for any home oxygen.  Patient will be discharged to home with oral antibiotic for completion.  Per patient's request VNA and COVID safe at home has been ordered for patient.  Patient recommended follow-up with his PCP within 1 week.
Age: 0.17
Sex: F
Vaccine: RV1
Symptoms: Incorrect route of product administration, Injection site nodule, Irritability
Clinical narrative: Patient received an intramuscular dose of an oral vaccine. Patient recovered well without incident; she was just fussy on the day of receipt of 4 IM injections (instead of 3 with 1 oral dose) with a small knot on both sides where the injections were administered.
Age: 51.0
Sex: U
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Urticaria chronic
Clinical narrative: Worsening of Chronic Hives, see statement on previous page.  Symptoms started days to weeks after the booster shot and have not cleared.  In fact, more than a month later they appear to be getting worse as my Zyrtec intake keeps having to be increased to control the hives.   Statement from previous page: "Since getting my booster my hives are not well controlled and I am now having to take 20mg - 30mg of Zyrtec per day to control them.  These reports are rampant across Chronic Urticaria boards including reports of people who did not have CU until after they received the vaccine and / or booster.  This is an issue that desperately needs to be looked into as when my CU and food sensitivities first started many years ago it was after my very first known flu vaccine.  It would seem as though there is some kind of connection between vaccines triggering  CU in certain individuals. And I will state, when uncontrolled this is a condition you would not wish on your worst enemy.  It's miserable and totally degrades your quality of life. "
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Presyncope, Syncope, Unresponsive to stimuli, Vision blurred
Clinical narrative: PATIENT HAD A VASOVAGAL REACTION AND FAINTED AFTER RECEIVING VACCINE. WAS UNRESPONSIVE WHILE SITTING IN CHAIR FOR ABOUT 5 SECONDS THEN RECOVERED. STATED SHE HAD BLURRY VISION AND COULDN'T FEEL HER FINGERS HOWEVER AFTER ROUGHLY 30 SECONDS SHE REGAINED HER VISION AND WAS ABLE TO MOVE HER FINGERS AND TOES. EMS WAS CALLED ONCE PATIENT HAD FAINTED AND ASSESSED HER ONCE THEY ARRIVED AFTER SHE HAD RECOVERED. NORMAL BP AND HR WAS FOUND ALONG WITH NORMAL BLOOD GLUCOSE LEVEL.
Age: 14.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood glucose decreased, Coronavirus infection, Coronavirus test positive, Decreased appetite
Clinical narrative: Patient was brought into outside hospital with weakness as well as coronavirus symptoms.  Patient had positive home coronavirus test which was confirmed as positive outside hospital.  Initial laboratory evaluation showed a blood glucose of 48. Due to this an IV was established and patient was started on D10.  Due to her hypoglycemia as well as disordered eating the decision was made to transfer the patient to the  hospital service for further evaluation management of care.  Medical Level of Care is being upgraded from Observation on 1/24/22 to Inpatient because she has a current diagnosis of dehydration, with poor ability to keep hydrated at home. Anorexia with hyperglycemia as well as coronavirus positive.
Age: 14.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dehydration, Eating disorder, Fluid intake reduced, Hyperglycaemia, Hypoglycaemia
Clinical narrative: Patient was brought into outside hospital with weakness as well as coronavirus symptoms.  Patient had positive home coronavirus test which was confirmed as positive outside hospital.  Initial laboratory evaluation showed a blood glucose of 48. Due to this an IV was established and patient was started on D10.  Due to her hypoglycemia as well as disordered eating the decision was made to transfer the patient to the  hospital service for further evaluation management of care.  Medical Level of Care is being upgraded from Observation on 1/24/22 to Inpatient because she has a current diagnosis of dehydration, with poor ability to keep hydrated at home. Anorexia with hyperglycemia as well as coronavirus positive.
Age: 14.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise
Clinical narrative: Patient was brought into outside hospital with weakness as well as coronavirus symptoms.  Patient had positive home coronavirus test which was confirmed as positive outside hospital.  Initial laboratory evaluation showed a blood glucose of 48. Due to this an IV was established and patient was started on D10.  Due to her hypoglycemia as well as disordered eating the decision was made to transfer the patient to the  hospital service for further evaluation management of care.  Medical Level of Care is being upgraded from Observation on 1/24/22 to Inpatient because she has a current diagnosis of dehydration, with poor ability to keep hydrated at home. Anorexia with hyperglycemia as well as coronavirus positive.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint range of motion decreased
Clinical narrative: Patient got vaccination on 11/23/21. Reported to pharmacist that she has had shoulder pain and trouble with moving her should (limited range of motion) since that time. Has seen MD and been prescribed medications and is still experiencing issues with pain and limited range of motion.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Headache, Oropharyngeal pain
Clinical narrative: I had fever, chill, body ache, sore throat, congestive, cough and headache.  These lasted for about 5 days.  On Jan 17th, I was tested positive for Covid-19 test.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had fever, chill, body ache, sore throat, congestive, cough and headache.  These lasted for about 5 days.  On Jan 17th, I was tested positive for Covid-19 test.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Asthenia, Balance disorder, Blood creatinine increased
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/17/21 (EN6200) Pfizer Dose 2 3/11/21 (EN6208) COVID Positive 10/4/21  10/4/21: Patient is a direct admit from ER.  A past medical history is significant with diabetes, CKD , CAD with stents, and deficiency anemia sleep apnea, hypertension.  She presented to the ER with complaints of losing balance, generalized weakness and frequent falls at home.  She is from home with her husband who called EMS services.  Upon arrival to the ER she was noted with a black left eye and has been reporting she fell out of the bed.   Blood work was completed at ER was significant with sodium 129, creatinine 2.3, D-dimer 1.21. She also has a positive urine and a positive COVID 19 test positive.  Due to her elevated creatinine a CTA was not done.  The patient was noted hypoxia requiring 2 L nasal cannula.   Upon arrival to medical unit the patient was noted with SpO2 86% on 12 L oxygen.  Respiratory eval and treat was ordered.  She was then transferred to ICU for close monitoring. Pulmonology consultation initiated. For transferring to ICU I addressed patient's goals of care and she was to continue with full treatment.  She refused to to be intubated if needed.  I discussed the plan of care with the patient and she is agreeable to stay in hospital for further management  10/9/21: Patient is a 74-year-old female who was admitted on 10/4/2021 with acute hypoxic respiratory failure, secondary to bilateral COVID pneumonia, elevated LFTs, secondary to COVID, AKI on CKD, and E coli UTI.  She was noted to be very weak and has been suffering frequent falls.  This is thought to be complicated by excessive amounts of lorazepam at home (3mg @hs).  She was admitted to the ICU.  Critical care intensivist was consulted.  She was started on IV Levaquin, IV corticosteroids, and supplemental oxygen.  Blood cultures and sputum culture were ordered.  Lorazepam was discontinued.  Her urine culture showed positive for E coli, resistant to Levaquin. Levaquin was discontinued and Rocephin and Azithromycin were started.  The patient has slowly improved.  She is currently only requiring 4 L of supplemental oxygen by nasal cannula.  Physical therapy evaluated her and recommended SNF placement.  Her vitals have been stable otherwise.  Blood pressures were mildly elevated, so the patient's amlodipine was increased to 10 mg p.o. daily. Labs have been unremarkable.  Patient is being discharged to swing bed.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture, Blood pressure increased, Blood sodium decreased, Blood test, COVID-19
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/17/21 (EN6200) Pfizer Dose 2 3/11/21 (EN6208) COVID Positive 10/4/21  10/4/21: Patient is a direct admit from ER.  A past medical history is significant with diabetes, CKD , CAD with stents, and deficiency anemia sleep apnea, hypertension.  She presented to the ER with complaints of losing balance, generalized weakness and frequent falls at home.  She is from home with her husband who called EMS services.  Upon arrival to the ER she was noted with a black left eye and has been reporting she fell out of the bed.   Blood work was completed at ER was significant with sodium 129, creatinine 2.3, D-dimer 1.21. She also has a positive urine and a positive COVID 19 test positive.  Due to her elevated creatinine a CTA was not done.  The patient was noted hypoxia requiring 2 L nasal cannula.   Upon arrival to medical unit the patient was noted with SpO2 86% on 12 L oxygen.  Respiratory eval and treat was ordered.  She was then transferred to ICU for close monitoring. Pulmonology consultation initiated. For transferring to ICU I addressed patient's goals of care and she was to continue with full treatment.  She refused to to be intubated if needed.  I discussed the plan of care with the patient and she is agreeable to stay in hospital for further management  10/9/21: Patient is a 74-year-old female who was admitted on 10/4/2021 with acute hypoxic respiratory failure, secondary to bilateral COVID pneumonia, elevated LFTs, secondary to COVID, AKI on CKD, and E coli UTI.  She was noted to be very weak and has been suffering frequent falls.  This is thought to be complicated by excessive amounts of lorazepam at home (3mg @hs).  She was admitted to the ICU.  Critical care intensivist was consulted.  She was started on IV Levaquin, IV corticosteroids, and supplemental oxygen.  Blood cultures and sputum culture were ordered.  Lorazepam was discontinued.  Her urine culture showed positive for E coli, resistant to Levaquin. Levaquin was discontinued and Rocephin and Azithromycin were started.  The patient has slowly improved.  She is currently only requiring 4 L of supplemental oxygen by nasal cannula.  Physical therapy evaluated her and recommended SNF placement.  Her vitals have been stable otherwise.  Blood pressures were mildly elevated, so the patient's amlodipine was increased to 10 mg p.o. daily. Labs have been unremarkable.  Patient is being discharged to swing bed.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chronic kidney disease, Condition aggravated, Culture urine positive, Escherichia infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/17/21 (EN6200) Pfizer Dose 2 3/11/21 (EN6208) COVID Positive 10/4/21  10/4/21: Patient is a direct admit from ER.  A past medical history is significant with diabetes, CKD , CAD with stents, and deficiency anemia sleep apnea, hypertension.  She presented to the ER with complaints of losing balance, generalized weakness and frequent falls at home.  She is from home with her husband who called EMS services.  Upon arrival to the ER she was noted with a black left eye and has been reporting she fell out of the bed.   Blood work was completed at ER was significant with sodium 129, creatinine 2.3, D-dimer 1.21. She also has a positive urine and a positive COVID 19 test positive.  Due to her elevated creatinine a CTA was not done.  The patient was noted hypoxia requiring 2 L nasal cannula.   Upon arrival to medical unit the patient was noted with SpO2 86% on 12 L oxygen.  Respiratory eval and treat was ordered.  She was then transferred to ICU for close monitoring. Pulmonology consultation initiated. For transferring to ICU I addressed patient's goals of care and she was to continue with full treatment.  She refused to to be intubated if needed.  I discussed the plan of care with the patient and she is agreeable to stay in hospital for further management  10/9/21: Patient is a 74-year-old female who was admitted on 10/4/2021 with acute hypoxic respiratory failure, secondary to bilateral COVID pneumonia, elevated LFTs, secondary to COVID, AKI on CKD, and E coli UTI.  She was noted to be very weak and has been suffering frequent falls.  This is thought to be complicated by excessive amounts of lorazepam at home (3mg @hs).  She was admitted to the ICU.  Critical care intensivist was consulted.  She was started on IV Levaquin, IV corticosteroids, and supplemental oxygen.  Blood cultures and sputum culture were ordered.  Lorazepam was discontinued.  Her urine culture showed positive for E coli, resistant to Levaquin. Levaquin was discontinued and Rocephin and Azithromycin were started.  The patient has slowly improved.  She is currently only requiring 4 L of supplemental oxygen by nasal cannula.  Physical therapy evaluated her and recommended SNF placement.  Her vitals have been stable otherwise.  Blood pressures were mildly elevated, so the patient's amlodipine was increased to 10 mg p.o. daily. Labs have been unremarkable.  Patient is being discharged to swing bed.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Eye contusion, Fall, Fibrin D dimer increased, Hypoxia, Intensive care
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/17/21 (EN6200) Pfizer Dose 2 3/11/21 (EN6208) COVID Positive 10/4/21  10/4/21: Patient is a direct admit from ER.  A past medical history is significant with diabetes, CKD , CAD with stents, and deficiency anemia sleep apnea, hypertension.  She presented to the ER with complaints of losing balance, generalized weakness and frequent falls at home.  She is from home with her husband who called EMS services.  Upon arrival to the ER she was noted with a black left eye and has been reporting she fell out of the bed.   Blood work was completed at ER was significant with sodium 129, creatinine 2.3, D-dimer 1.21. She also has a positive urine and a positive COVID 19 test positive.  Due to her elevated creatinine a CTA was not done.  The patient was noted hypoxia requiring 2 L nasal cannula.   Upon arrival to medical unit the patient was noted with SpO2 86% on 12 L oxygen.  Respiratory eval and treat was ordered.  She was then transferred to ICU for close monitoring. Pulmonology consultation initiated. For transferring to ICU I addressed patient's goals of care and she was to continue with full treatment.  She refused to to be intubated if needed.  I discussed the plan of care with the patient and she is agreeable to stay in hospital for further management  10/9/21: Patient is a 74-year-old female who was admitted on 10/4/2021 with acute hypoxic respiratory failure, secondary to bilateral COVID pneumonia, elevated LFTs, secondary to COVID, AKI on CKD, and E coli UTI.  She was noted to be very weak and has been suffering frequent falls.  This is thought to be complicated by excessive amounts of lorazepam at home (3mg @hs).  She was admitted to the ICU.  Critical care intensivist was consulted.  She was started on IV Levaquin, IV corticosteroids, and supplemental oxygen.  Blood cultures and sputum culture were ordered.  Lorazepam was discontinued.  Her urine culture showed positive for E coli, resistant to Levaquin. Levaquin was discontinued and Rocephin and Azithromycin were started.  The patient has slowly improved.  She is currently only requiring 4 L of supplemental oxygen by nasal cannula.  Physical therapy evaluated her and recommended SNF placement.  Her vitals have been stable otherwise.  Blood pressures were mildly elevated, so the patient's amlodipine was increased to 10 mg p.o. daily. Labs have been unremarkable.  Patient is being discharged to swing bed.